Pipelines

(Image: Getty/Nordroden)

Gavi sets aside $178m to stockpile Ebola vaccines

By Ben Hargreaves

Gavi establishes an Ebola vaccine program for the next five years, with a stockpile of vaccines created to be made available to low- and middle-income countries free of charge.

(Image: Getty/Photo world)

WuXi Vaccines to build $240m facility in Ireland

By Ben Hargreaves

WuXi Biologics furthers its manufacturing presence in Ireland with a manufacturing facility for its vaccines subsidiary, which will be able to produce both drug substance and drug product.

(Image: Getty/LightFieldStudios)

Amgen joins neuroscience exodus

By Ben Hargreaves

In third quarter financials, Amgen announces that it will end its R&D efforts in neuroscience to focus on diseases with a ‘large public health impact.

(Image: Getty/Golubovy)

Top five stories from September

By Ben Hargreaves

The news most interesting to our readers were those featuring collaborations, whether in the production of an Ebola vaccine, biosimilars entering new markets or creating new manufacturing modalities.

Follow us

Webinars